Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
Catherine J. Edwards-Smith, Julie R. Jonsson, David M. Purdie et al. · Hepatology · 1999
Serum levels of interleukin-10 (IL-10) are elevated in a proportion of patients with untreated chronic hepatitis C, and this may compromise the host immune response to the virus. The capacity for IL-10 production varies according to the genetic composition of the IL-10 locus. We examined the inheritance of 3 biallelic polymorphisms in the IL-10 gene promoter in patients with chronic hepatitis C and their association with response to treatment with interferon alfa (IFN-alpha). After adjusting for potential confounding variables, a highly significant relationship was found between inheritance of the IL-10 promoter -592*A and -819*T alleles or the ATA haplotype and response to IFN-alpha therapy (P =.016). Response to treatment was also associated with viral genotype 3a, a low viral load, and less fibrosis on liver biopsy. Following in vitro stimulation of peripheral blood mononuclear cells, the IL-10 promoter haplotypes, GCC, ACC, and ATA, were associated with high, intermediate, and low IL-10 production, respectively. These findings indicate that heterogeneity in the promoter region of the IL-10 gene has a role in determining the initial response of chronic hepatitis C to IFN-alpha therapy. Patients who are genetically predisposed to high IL-10 production have a poor response to IFN-alpha and may benefit from additional treatment strategies designed to enhance a T-helper type 1 (Th1) response.
Cited by 404 works. doi:10.1002/hep.510300207 Open-access PDF
Authors
- Catherine J. Edwards-Smith
- Julie R. Jonsson
- David M. Purdie
- Amolak Singh Bansal
- Claudia Shorthouse
- Elizabeth Ellen Powell
References
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
- Classification of chronic viral hepatitis: a need for reassessment
- IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
- AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTER
- The Treatment of Chronic Viral Hepatitis
- Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.
- Hepatitis C: The clinical spectrum of disease
- Genetic influence on cytokine production and fatal meningococcal disease
- Properties and Functions of Interleukin-10